First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers
David M. Fairlamb, Kinga Szepeshazi, David Goldsmith, Peter Danos et autres
We report the first clinical evaluation of a new enzymatic wound debridement product containing tarumase in venous leg ulcer patients. As a first-in-human study, this was a prospective, open-label, multi-centre, dose escalation study across five dose cohorts and involving a total of …
gb, hu, us (code pays fourni par la source)
3 citations
International Wound Journal